Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Alkermes PLC Raises FY 2013 Guidance


Thursday, 31 Jan 2013 07:00am EST 

Alkermes PLC announced that it is improving its financial expectations for fiscal 2013, reflecting increased net sales expectations for VIVITROL and decreased research and development (R&D) expense expectations. For fiscal 2013, the Company now expects total revenues to range from $520 million to $545 million, up from a range of $510 million to $540 million, GAAP net income to range from break-even to positive $15 million, or a basic and diluted EPS of approximately $0.00 to $0.11. This compares to previous expectations of a GAAP net loss in the range of break-even to $15 million, or a basic and diluted loss per share of approximately $0.00 to $0.11. The Company now expects fiscal 2013 non-GAAP net income to range from $135 million to $155 million, and non-GAAP diluted EPS to range from $0.99 to $1.13. This compares to previous expectations of non-GAAP net income in the range of $120 million to $140 million and non-GAAP diluted EPS in the range of $0.88 to $1.02. 

Related Company News

Company Quote

45.91
0.63 +1.39%
17 Oct 2014